Glutathione-deficient Plasmodium berghei parasites exhibit growth delay and nuclear DNA damage  by Padín-Irizarry, Vivian et al.




















3 Bojournal homepage: www.elsevier.com/locate/freeradbiomedOriginal ContributionGlutathione-deﬁcient Plasmodium berghei parasites exhibit growth
delay and nuclear DNA damage
Vivian Padín-Irizarry a,1, Emilee E. Colón-Lorenzo a, Joel Vega-Rodríguez a,2,
María del R. Castro b, Ricardo González-Méndez c, Sylvette Ayala-Peña b,3,
Adelfa E. Serrano a,3,n
a Department of Microbiology and Medical Zoology, University of Puerto Rico, School of Medicine, San Juan 00936-5067, Puerto Rico
b Department of Pharmacology and Toxicology, University of Puerto Rico, School of Medicine, San Juan 00936-5067, Puerto Rico
c Department of Radiological Sciences, University of Puerto Rico, School of Medicine, San Juan 00936-5067, Puerto Ricoa r t i c l e i n f o
Article history:
Received 9 May 2015
Received in revised form
26 February 2016
Accepted 28 February 2016









49/& 2016 The Authors. Published by Elsevier
viations: ART, artemisinin; DCF, dichloroﬂ
ihydroﬂuorescein; DHOD, dihydroorotate deh
ylhydrazine; FP IX, ferritoprotoporphyrin IX;
e; GR, glutathione reductase; Grx, Glutaredox
one disulﬁde; H2O2, hydrogen peroxide; Hb, h
rial DNA; nDNA, nuclear DNA; pbggcs-ko, P. b
nthetase knockout; pbgr-ko, P. berghei glutathi
ate-buffered saline; PPP, Pentose phosphate p
rase chain reaction; RBC, red blood cells; RNR
ctive oxygen species; SOD, superoxide dismu
e; γGCS, gamma glutamylcysteine synthetase
esponding author.
ail address: adelfa.serrano@upr.edu (A.E. Serra
esent address: Department of Global Health
FL 33612, USA.
esent address: The W. Harry Feinstone Depa
and Immunology, Malaria Research Institute
Johns Hopkins University, Baltimore, MD 212
th authors contributed equally to this work.a b s t r a c t
Plasmodium parasites are exposed to endogenous and exogenous oxidative stress during their complex
life cycle. To minimize oxidative damage, the parasites use glutathione (GSH) and thioredoxin (Trx) as
primary antioxidants. We previously showed that disruption of the Plasmodium berghei gamma-gluta-
mylcysteine synthetase (pbggcs-ko) or the glutathione reductase (pbgr-ko) genes resulted in a signiﬁcant
reduction of GSH in intraerythrocytic stages, and a defect in growth in the pbggcs-ko parasites. In this
report, time course experiments of parasite intraerythrocytic development and morphological studies
showed a growth delay during the ring to schizont progression. Morphological analysis shows a sig-
niﬁcant reduction in size (diameter) of trophozoites and schizonts with increased number of cytoplasmic
vacuoles in the pbggcs-ko parasites in comparison to the wild type (WT). Furthermore, the pbggcs-ko
mutants exhibited an impaired response to oxidative stress and increased levels of nuclear DNA (nDNA)
damage. Reduced GSH levels did not result in mitochondrial DNA (mtDNA) damage or protein carbo-
nylations in neither pbggcs-ko nor pbgr-ko parasites. In addition, the pbggcs-ko mutant parasites showed
an increase in mRNA expression of genes involved in oxidative stress detoxiﬁcation and DNA synthesis,
suggesting a potential compensatory mechanism to allow for parasite proliferation. These results reveal
that low GSH levels affect parasite development through the impairment of oxidative stress reduction
systems and damage to the nDNA. Our studies provide new insights into the role of the GSH antioxidant
system in the intraerythrocytic development of Plasmodium parasites, with potential translation into
novel pharmacological interventions.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
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05, USA.1. Introduction
Malaria remains the most deadly parasitic disease resulting in
approximately 584,000 deaths from 198 million clinical cases re-
ported in 2013 and one-third of the world population at risk of
infection [1]. This disease is caused by the apicomplexan parasites
of the genus Plasmodium, which are transmitted to humans by the
bite of infected Anopheles mosquitoes.
Plasmodium parasites are exposed to multiple sources of oxi-
dative stress throughout their complex life cycle. During the in-
traerythrocytic development, endogenous oxidative stress results
from reactive oxygen species (ROS) produced during hemoglobin
(Hb) digestion in the parasite’s food vacuole [2,3]. In addition, the
parasite is exposed to exogenous oxidative stress when merozoites
egress from the red blood cells (RBC), inducing the production of
nitric oxide and ROS by the host’s immune system [2,4]. Plasmo-
dium parasites depend on two major NADPH-dependent redoxnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ROS and prevent oxidative damage [5].
Plasmodium synthesizes GSH by the sequential action of the
rate limiting enzyme γ-glutamylcysteine synthetase (γ-GCS), and
the glutathione synthetase [6]. The reduced GSH is oxidized to
GSH disulﬁde (GSSG) by the reduction of glutaredoxin or glu-
tathione-S-transferase (GST) [3,6,7]. The oxidized GSSG is reduced
back to GSH by the glutathione reductase (GR), maintaining the
GSH/GSSG ratio in the cell [8]. Glutathione plays an important role
in a wide range of cellular processes including the detoxiﬁcation of
xenobiotics and protection against ROS [7,9,10]. In Plasmodium
parasites, GSH is also involved in the degradation of the toxic
ferritoprotoporphyrin IX (FP IX), escaped from hemozoin forma-
tion [11]. Additionally, GSH functions as an electron donor for the
enzyme ribonucleotide reductase (RNR), [12,13], crucial for DNA
synthesis and cellular proliferation [2,3,10].
Previous reports from our laboratory demonstrated that dis-
ruption of the pbggcs gene in Plasmodium berghei resulted in
mutant parasites displaying reduced GSH levels and growth im-
pairment during intraerythrocytic development [14]. Moreover,
disruption of the pbggcs gene inhibited oocyst development and
the production of sporozoites in the mosquito, indicating that GSH
biosynthesis is critical to complete parasite transmission [14]. Si-
milarly, P. berghei parasites with a disrupted glutathione reductase
(pbgr-ko) gene displayed signiﬁcantly reduced GSH levels and in-
terruption of parasite development in the mosquito, with parasites
arrested at the oocyst stage [15]. Although the relevance of GSH for
parasite development has been shown, the underlying mechan-
isms of the delayed parasite development as a consequence of
reduced GSH levels as well as the oxidative status of the mutant
parasites deserves further investigation.
In this study, we further characterized the effects of reduced
GSH levels in P. berghei and demonstrate that parasites with sig-
niﬁcantly low levels of GSH show a growth delay during the ring to
schizont transition, have signiﬁcantly smaller trophozoites and
schizonts and a vacuolated cytoplasm. These changes occur con-
comitantly with an impairment capacity to handle oxidative stress
and increased levels of nDNA damage. These results show for the
ﬁrst time a causal interplay between low GSH levels, impaired
response to oxidative stress, oxidative DNA damage, and delayed
parasite growth during the ring to schizont transition. The ﬁndings
presented herein provide a better understanding of the need for
maintaining GSH homeostasis during P. berghei development. Be-
cause the redox balance plays a vital role for parasite survival, our
results have important applications for antimalarial treatments.
Strategies aiming to promote oxidative stress and/or inhibiting the
parasite antioxidant system will lead to a redox imbalance af-
fecting parasite growth, and therefore a potential improvement in
treatment response.2. Materials and methods
2.1. Mice and P. berghei lines
Random-bred Swiss albino CD-1 female mice (Charles River
Laboratories, Wilmington, MA, USA), 6–8 weeks old, weighing 20–
35 g were used for the study. All mice procedures were conducted
at the AAALAC accredited University of Puerto Rico Medical Sci-
ences Campus (UPR-MSC) Animal Resources Center and approved
by the Institutional Animal Care and Use Committee (IACUC). All
work was done in strict accordance with the “Guide for the Care
and Use of Laboratory Animals” (National-Research-Council, Cur-
rent Edition) and regulations of the PHS Policy on Humane Care
and Use of Laboratory Animals. Mice were maintained and housed
according to NIH and AAALAC regulations and guidelines. Micewere allowed to acclimatize for 1 week prior to the beginning of
the studies. The P. berghei ANKAWT, reference line (507cl1), which
expresses green ﬂuorescent protein under the control of the
constitutive eukaryotic elongation factor 1A promoter, was used as
a control in all experiments [16]. The following P. berghei lines
(mutants) were included in the study: pbggcs-ko1 and pbggcs-ko2
[14], and pbgr-ko1 and pbgr-ko2 [15].
2.2. Intraerythrocytic growth assay
To investigate the delayed parasitemia of pbggcs-ko parasites in
mice [14], WT and pbggcs-ko parasites were synchronized in in
vitro cultures as described by Janse and Waters [17]. Brieﬂy, P.
berghei infected blood was harvested from mice with 5–15%
parasitemia, diluted in complete medium [RPMI 1640 (Gibcos),
25% heat inactivated fetal bovine serum (Gibcos), 50 IU/ml of
neomycin (Sigma)] and cultured for 24–26 h at 37 °C in an atmo-
sphere of 10% O2, 5% CO2 and 85% N2 gas mixture. The schizonts
were puriﬁed by 55% Nycodenz gradient [17] and injected in-
travenously into mice [18]. The synchronized ring infected blood
was collected from mice 4–6 h post infection and cultured in vitro
for a total of 28 h. The parasite intraerythrocytic development was
analyzed by light microscopy of Diff-Quick stained thin smears in
samples collected every 2 h, beginning after the initial 16 h of
culture. Parasite intraerythrocytic developmental stages (rings,
trophozoites and schizonts) and morphology were determined by
counting at least 100 parasites per slide. Images were acquired
with a microscope (BX51, Olympus) at 100 magniﬁcation using a
digital camera (DP72, Olympus). The size of trophozoites and
schizonts stages was assessed at 16, 24 and 28 h and vacuoles at
16 h in WT, pbggcs-ko1 and pbggcs-ko2 parasites using a calibrated
ocular micrometer at 100 magniﬁcation (n¼20).
2.3. Determination of intraparasitic response to oxidative stress le-
vels by measuring the oxidation of 2′,7′-dichlorodihydroﬂuorescein
(DCFH).
To determine the levels of intraparasitic response to oxidative
stress, the ﬂuorescent intensity of dichloroﬂuorescein (DCF), the
green ﬂuorescent oxidation product of DFCH, was determined in
WT and pbggcs-ko parasites cultured in vitro. The DCF ﬂuorescent
intensity was measured in the basal (untreated) or hydrogen
peroxide (H2O2)-treated cultures as described by Trivedi et al. [19].
Brieﬂy, P. berghei infected blood was cultured, as previously de-
scribed, in the presence or absence of 2 mM H2O2 for 1 h. The
cultures were then incubated with 10 μM of 2′,7′-dichloro-
ﬂuorescein diacetate for 30 min at 37 °C, washed with 0.01 M,
potassium phosphate buffer (PBS) (pH 7.4), centrifuged and sub-
sequently lysed with saponin (0.15%) for 10 min at 4 °C. Parasites
were isolated by centrifugation at 1300g for 5 min at 10 °C and
lysed by sonication (30 s pulse, bath-type sonicator) at 4 °C.
Fluorescent intensities were recorded from the lysates in a spec-
troﬂuorometer (SpectraMaxs M3, Molecular Devices©) at 502 nm
and 523 nm excitation and emission wavelengths, respectively.
Protein concentrations were determined in each well using the
Pierce™ Modiﬁed Lowry Protein Assay Kit (Thermo Scientiﬁc) and
data was expressed as ﬂuorescence intensity/milligram of parasite
lysate protein.
2.4. DNA isolation and quantiﬁcation
High molecular weight genomic DNA was isolated from WT,
pbggcs-ko and pbgr-ko parasites using a Genomic DNA extraction
Kit (Qiagen©) following the manufacturer’s instructions. Quanti-
ﬁcation of DNA was performed using the PicoGreens dsDNA
Quantitation Reagent (Molecular Probess) with modiﬁcations as
Table 1
Non-linear ﬁt Weibull growth model.
Best-ﬁt values WT pbggcs-ko1 pbggcs-ko2
YM 72.22 41.24 12.20
Y0 1.366 0.4789 0.3949
k 0.04333 0.04197 0.04640
g 15.14 11.65 11.15
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of the samples, a DNA standard curve was constructed using
lambda DNA. The PicoGreens excitation and emission ﬂuores-
cence intensities were measured at 485 nm and 530 nm, respec-
tively, using a ﬂuorescence microplate reader (Wallac 1420
Victor2™, PerkinElmer). The integrity of the genomic DNA was
examined by analyzing the samples in a 0.8% ethidium bromide-
containing agarose gel. The DNAwas visualized using UV light (Gel
Doc™ XR System, Bio-Rad).
2.5. Analysis of nuclear and mitochondrial DNA damage using the
quantitative polymerase chain reaction (QPCR) assay
A QPCR assay was modiﬁed to determine the levels of DNA
damage to the parasite’s nuclear and mitochondrial genomes as
we previously described [22]. The underlying principle of the
QPCR assay is that certain types of DNA lesions will prevent the
DNA polymerase to effectively replicate the DNA fragment;
thereby resulting in a decrease in the ampliﬁcation yield. To en-
sure that the QPCR assay was performed within the linear range of
ampliﬁcation, optimal conditions for ampliﬁcation of the nDNA
and mtDNA fragments were determined by performing cycle and
template tests. The initial DNA template concentration used for the
ampliﬁcation of nDNA and mtDNA was 5 ng and 7.5 ng, respec-
tively. As a control to ensure quantitative conditions of ampliﬁ-
cation, a DNA sample with two fold the initial quantity of DNA
concentration (10 ng and 15 ng of nDNA and mtDNA template,
respectively) was ampliﬁed in duplicate. A 40–60% increase in
ampliﬁcation of the control target sequence was considered within
the linear range of ampliﬁcation and adequate for data analysis. To
detect nDNA lesions a 6.1 kb fragment from the seryl-tRNA syn-
thetase nuclear gene was ampliﬁed using the MasterAmp™ Extra-
long PCR Reagents (Epicentres). An initial denaturation was car-
ried out for 45 s at 94 °C, 24 cycles of denaturation for 15 s at 94 °C,
annealing-extension at 68 °C for 12 min, and a ﬁnal extension at
72 °C for 10 min using the following primers: 5′-CACTATCAACA-
TATTCATCTCTTGTTTC-3′ (forward) and 5′-GCTCTATGGACACCAA-
TAGTTCCAAGGG-3′ (reverse).
To detect mtDNA lesions a fragment of 5.7 kb of the mi-
tochondrial genome was ampliﬁed using 5′-GAATAGTGGTA-
TAGTCATATCTCCATGAAC-3′ (forward) and 5′-TGGTATCTCG-
TAATGTAGAACAATAATAGG-3′ (reverse) as primers. The ampliﬁ-
cation conditions consisted on an initial denaturation for 45 s at
94 °C, 21 cycles of denaturation for 15 s at 94 °C and annealing-
extension at 68 °C for 12 min, and a ﬁnal extension at 72 °C for
10 min.
To conﬁrm that a single product of the expected size was ob-
tained, the 6.1 kb and 5.7 kb PCR products were resolved on 1%
ethidium bromide-stained agarose gels and visualized using UV-
light (Gel Doc™ XR System, Bio-Rad). Nuclear and mitochondrial
PCR products were quantiﬁed using PicoGreens. The background
ﬂuorescence was obtained from a sample without DNA template
and subtracted from each experimental sample [20]. Background
values were determined in duplicate. The results of P. berghei
mutant parasites are expressed as DNA ampliﬁcation levels re-
lative to the levels of DNA ampliﬁcation from WT parasites.
2.6. Quantiﬁcation of mtDNA abundance by quantitative polymerase
chain reaction (QPCR) assay
Because the number of mtDNA molecules vary between cells, it
was critical to make certain that the ampliﬁcation of the 5.7 kb
mtDNA fragment was not affected by possible changes in the
abundance of mtDNA molecules. A small mtDNA fragment of
186 bp was ampliﬁed to provide a precise measure of mtDNA
molecules/abundance because small DNA fragments are unlikelyto be damaged. Cycle and template tests were performed to es-
tablish optimal conditions of ampliﬁcation. To assure quantitative
PCR conditions, a DNA sample with 50% of the initial quantity of
DNA concentration (2.5 ng) was ampliﬁed in duplicate. The PCR
proﬁle consisted on an initial denaturation for 45 s at 94 °C, 25
cycles of denaturation for 15 s at 94 °C, annealing for 45 s at 60 °C
and extension for 45 s at 72 °C, and a ﬁnal extension at 72 °C for
10 min. The primer nucleotide sequences for the ampliﬁcation of
the 186 bp mtDNA fragment are 5′-ATTAACAACTA-
TAGCATTATCTGGATGAGA-3′ (forward) and 5′-TTCTTTTTACATTTA-
CATGGTAGCACTAAT-3′ (reverse). PCR products were quantiﬁed
using PicoGreens after subtracting the background ﬂuorescence.
To conﬁrm that a single product of 186 bp was ampliﬁed, PCR
products were resolved on ethidium bromide-stained 2% poly-
acrylamide gels and visualized under UV-light (Gel Doc™ XR
System, Bio-Rad). The abundance of mtDNA molecules of P. berghei
mutant parasites is expressed relative to the mtDNA abundance in
WT parasites.
2.7. Determination of DNA lesion frequencies
Because DNA lesions occur as independent events and, thus, are
randomly distributed across the genome, the Poisson equation was
used to calculate the frequency of DNA lesions per 10 kb/strand as
previously described [22]. Using the Poisson distribution,
( ) = λ λ− !f x e x
x
a decrease in ampliﬁcation is converted into lesion
frequency considering that ampliﬁcation is directly proportional to
the portion of undamaged DNA templates (zero class molecules;
x¼0). Then, the average lesion frequency per DNA strand can be
calculated as, λ = − A Aln /D O where AD denotes the amount of
ampliﬁcation product of the damaged DNA template and AO is the
ampliﬁcation product from undamaged DNA. The results of P.
berghei mutant parasites are expressed as a relative ampliﬁcation
ratio (AD/AO) and as lesion frequency per 10 kb per strand relative
to WT.
2.8. Quantiﬁcation of protein carbonylations by the FTC ﬂuorometric
assay
Blood containing P. berghei parasites were harvested from in-
fected mice with 5–15% parasitemia. White blood cells were re-
moved using a Plasmodipur ﬁlter (Euro-Diagnostica), washed with
0.01 M PBS (pH 7.4), and the RBC pellet resuspended in 0.01 M PBS
(pH 7.4), 1 mM DTT, 0.5 mM PMSF and 1 mM EGTA followed by
RBC lysis with 0.15% saponin. Samples were centrifuged at 1077g
for 8 min and the parasite pellet was resuspended in protein iso-
lation buffer (1% DOC and 10% SDS) containing a cocktail of pro-
tease inhibitors (0.01 mg of leupeptin A, 0.001 mg of pepstatin A,
0.35 mg of PMSF). The supernatant was collected, and DTT was
added to a ﬁnal concentration of 75 mM, to avoid spontaneous
protein oxidation, and stored at 80 °C until further use. The
protein concentration was determined using the Bicinchoninic
acid (BCA) assay (Bio-Rad DC™ Protein Assay) or the RC DC™
Protein Assay (Bio-Rad). Infected blood was cultured for 24–28 h
in complete RPMI medium in a low oxygen (10%) atmosphere as
described above. Schizont cultures were harvested, diluted with
Table 2
Correlation matrix analysis and p-values.
Parameter g Parameter k DNA damage GSH levels
Parameter g 0.786 0.504 0.013
Parameter k 0.330 0.282 0.798
DNA damage 0.703 0.904 0.517
GSH levels 1.000 0.311 0.688
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the parasite proteins as described above. Carbonyl content of
proteins was assessed in parasites from mice blood (rings, tro-
phozoites and schizonts) and in schizonts from cultures using a
modiﬁed ﬂuorometric assay [23]. Brieﬂy, proteins (60 mg) were
incubated with 50 ml of 0.2 mM ﬂuorescein 5-thiosemicarbazide
(FTC) overnight in the dark, precipitated with acetone, air dried,Fig. 1. In vitro development of WT and pbggcs-ko parasites: (A)–(C) Percentage of intraer
a 28 h time course. Three morphological stages were distinguished by microscopy: rings
size of trophozoites and schizonts stages from WT (white box), pbggcs-ko1 (light gray bo
(n¼20). (G) Representative images of intraerythrocytic stages of WT, pbggcs-ko1 and p
indicated by arrows. (H) Weibull growth model for the percentage of schizonts for W
ferences were observed between the WT parasites and the pbggcs-ko1 and pbggcs-ko2 m
measures ANOVA with Bonferroni multiple comparison test. Bars represen t the SEM frand solubilized with 50 ml of 6 M guanidine hydrochloride. Protein
precipitates were sonicated (30 s pulse, bath-type sonicator) for
10 min, vortexed, resuspended in 450 ml of 0.1 M PBS, vortexed,
centrifuged (10,000g for 10 min at 4 °C) and the supernatant ali-
quoted (150 ml/well) in triplicate into a black 96-well microplate
(Thermo Scientiﬁc™). The ﬂuorescence intensity was determined
in a spectroﬂuorometer (Wallac 1420 VICTOR F) with excitation at
485 nm and emission at 535 nm. Protein concentrations were
determined in each well using the Micro BCA™ Protein Assay Kit
(Pierce). The average of the ﬂuorescence readings and the protein
concentrations were measured in triplicate from 2 to 4 in-
dependent experiments. Nanomoles (nmol) of FTC-reacted car-
bonyls were calculated from the readings of FTC standard curve.
Carbonyl content was expressed as nmol/milligram of parasite
lysate protein.ythrocytic stages of WT (A), pbggcs-ko1 (B), and pbggcs-ko2 (C) parasites throughout
(white bars), trophozoites (light gray bars), and schizonts (dark gray bars). (D–F) The
x) and pbggcs-ko2 (dark gray box) parasites are shown at 16 (D), 24 (E) and 28 h (F)
bggcs-ko2 parasites at 16, 24 and 28 h of in vitro culture. Cytoplasmic vacuoles are
T (circle), pbggcs-ko1 (square) and pbggcs-ko2 (diamond) parasites. Signiﬁcant dif-
utant parasites (*po0.05, **po0.01, ***po0.001) analyzed by Two-way repeated
om 3 independent experiments.
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Total RNA from parasite intraerythrocytic stages (5–15% para-
sitemia) was extracted using Tri-Reagent (Molecular Research
Center, Inc.) following the manufacturer’s instructions. Com-
plementary DNA (cDNA) was synthesized using the SuperScripts
VILO kit (Life Technologies). The P. berghei sequences of target
genes were retrieved from PlasmoDB at plasmodb.org (Supple-
mental Table 1). Analysis of gene expression was done by RT-qPCR
using the StepOnePlus™ System (Applied Biosystems) with the
Fast SYBRs Green Master Mix and 50 ng/ml of cDNA per sample.
The samples were assayed in triplicate from three independent
experiments. Gene expression data was analyzed using the Ste-
pOne™ Software v2.2 (Applied Biosystems) and normalized
against the expression of 18S rRNA (Supplemental Table 1) [24]
according to the 2-△△Ct method [25,26]. Melt curve analysis was
used to conﬁrm the speciﬁcity of ampliﬁed PCR products.
2.10. Modeling of parasite growth
A non-linear curve ﬁt using the Weibull model for the growth
curve of the parasite schizonts stages was applied
= − ( − ) −( )Y Y Y Y e .M M kx0 g Parameters of this function were used to
determine the delay in growth of the WT and mutant parasites.
Speciﬁcally, YM corresponds to the maximum in the growth curve,
Y0 to the initial value of the growth curve, k to the time constant, g
corresponds to a parameter showing the inﬂection point of the
growth, and t represents time. The g values from the ﬁtted func-
tion were used to calculate the growth delay based on the para-
sitemia curves (Table 1).
2.11. Statistical analysis
Statistical analyses were performed using GraphPad Prism v 5.0
(GraphPad Software Inc.). A p-valueo0.05 was considered statis-
tically signiﬁcant. Comparisons of the parasite stage percentages
during parasitemia, and measurements of intraparasitic
response to oxidative stress in the presence or absence of external
H2O2, were made by Two-Way Analysis of Variance (Two-Way
ANOVA) with Repeated Measures with post-hoc testing using a t-
test with Bonferroni correction to account for multiple
comparisons.Fig. 2. P. berghei ggcs-ko parasites show increased levels of intracellular oxidative stress. D
and H2O2-treated in vitro cultures of WT, pbggcs-ko2 and pbgr-ko1 parasites. Cultures w
pbggcs-ko2 and pbgr-ko1 parasites. (B) H2O2-induced DCF ﬂuorescence intensity in WT, pb
H2O2-treated WT and pbggcs-ko2 (**po0.01, ***po0.001) and pbggcs-ko2 and pbgr-ko
analyzed by Two-way repeated measures ANOVA with Bonferroni multiple compariso
dependent experiments.Diameter of parasites, DNA damage and protein carbonylation
assays, were analyzed using One-Way ANOVA. A Two-Way ANOVA
was used for the RT-qPCR data analysis. Both analyses were done
using multiple comparisons with post-hoc testing using a t-test
with Bonferroni corrections. A correlation matrix analysis was
undertaken to ﬁnd if there were associations between the biolo-
gical variables measured and the parameters derived from the
Weibull growth model used to analyze the parasitemia curves. The
Pearson correlation coefﬁcient was used as a measure of associa-
tion. A p-value of 0.05 was used to determine if a correlation in the
matrix was signiﬁcant (Table 2).3. Results
3.1. Depleted GSH levels induce developmental delay and morpho-
logical changes during P. berghei intraerythrocytic growth
To assess the effects of GSH depletion on intraerythrocytic
growth, the ring to schizont transition was monitored in syn-
chronized cultures of the pbggcs-ko1 and pbggcs-ko2 parasites and
compared to WT parasites. Parasite clones from two independent
transfections with a disrupted ggcs gene (pbggcs-ko1 and pbggcs-ko2)
showed growth delay during the ring to schizont progression (Fig. 1).
As depicted in Fig. 1, panels A–C demonstrate an approximately 2-h
delay during the ring to trophozoite transition, and an approximately
4–6 h delay in the trophozoite to schizont transition. After 16 h, WT
parasite cultures contained 12.4% rings, 85.9% trophozoites and 1.7%
schizonts (Fig. 1A), while the mutant pbggcs-ko1 and pbggcs-ko2
parasites exhibit 33.3% and 41.1% rings (po0.05; po0.001) and
65.6% and 58.4% of trophozoites, respectively (Fig. 1B and C). Note
that at 16 h, the pbggcs-ko1 culture had only 1.1% of schizonts and no
schizonts were detected in the pbggcs-ko2 parasites (Fig. 1B and C).
At 28 h, WT parasite cultures displayed 23.5% trophozoites and 76.5%
schizonts, while the pbggcs-ko1 and the pbggcs-ko2 mutants pre-
sented 49.2% and 77.2% (po0.001) trophozoites, and 50.8% (po0.05)
and 22.8% schizonts (po0.001), respectively (Fig. 1B and C).
The growth curves were analyzed separately for schizonts
using a Weibull growth model. The results of the model ﬁtting are
shown in Table 1 and Fig. 1H. The non-linear ﬁt of the schizont
growth shows a decrease in the maximum level of growth of ap-
proximately 40–85% during the culture time period (Table 1), andCF ﬂuorescence intensity was determined at various time points in basal/untreated
ere treated with 2 mM H2O2 for 1 h: (A) basal levels of DCF ﬂuorescence in WT,
ggcs-ko2 and pbgr-ko1 parasites. Signiﬁcant differences were observed between the
1 mutant parasites (#po0.05, ##po0.01, ###po0.001) at different time points
n test. Bars represent the SD from 2 (pbgr-ko1) and SEM from 4 (pbggcs-ko2) in-
Fig. 3. P. berghei ggcs-ko2 mutant shows increased levels of nDNA damage:
(A) upper panel, representative gel showing the ampliﬁcation of a 6.1 kb nDNA
fragment of the seryl t-RNA synthetase gene from WT, pbggcs-ko and pbgr-ko
parasites. Lower panel, relative ampliﬁcation levels of the 6.1 kb nDNA fragment
from WT and mutant parasites. (B) Frequency of nDNA lesions per 10 kb per strand
was calculated as described in Section 2. Representative results of the 6.1 kb am-
pliﬁed fragment are shown in the upper panel. The 6 kb molecular weight marker
is indicated in the left. Signiﬁcant differences were observed between WT and
pbggcs-ko2 parasites (**po0.01, ***po0.001) analyzed by One-way ANOVA with
Bonferroni multiple comparison test. Bars represent the SEM from 3 independent
experiments and 10 QPCR analyses.
Fig. 4. Mutant parasites show no changes in the levels of mtDNA damage or
mtDNA abundance: (A) upper panel, representative gel showing the ampliﬁcation
of a 5.7 kb mtDNA fragment from WT, pbggcs-ko and pbgr-ko parasites. Lower
panel, relative ampliﬁcation of a 5.7 kb mtDNA fragment that was normalized for
changes in mtDNA abundance. (B) Upper panel, representative gel showing the
ampliﬁcation of the 186 bp mtDNA fragment. Lower panel, relative ampliﬁcation of
a 186 bp mtDNA fragment representative of mitochondrial abundance. No sig-
niﬁcant differences in mtDNA damage or mtDNA abundance were observed be-
tween WT and mutant parasites. Bars represent the SEM from 3 independent ex-
periments, and 14 and 12 QPCR analyses for mtDNA damage or mtDNA abundance,
respectively.
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presenting a 2-h growth delay (Fig. 1H).
The correlation matrix analysis showed that the inﬂection point
(growth delay) correlated with the GSH levels present in each
parasite clone (WT, 7.4 nmol/109 parasites; pbggcs-ko1,
1.0 nmol/109 parasites; pbggcs-ko2, 0.2 nmol/109 parasites [14])
(r2¼1.0, p¼0.013). The complete correlation matrix is shown in
Table 2. The upper triangular matrix shows the p values, while the
lower triangular matrix (shown in italics) shows the correlationcoefﬁcients. The only correlation that meets the statistical sig-
niﬁcance criterion is the association detected between the Weibull
model parameter g and the levels of GSH. Due to sparsity of the
data, more work is required to better understand this potentially
causal correlation.
Morphological changes in the GSH deﬁcient mutants, pbggcs-
ko1 and pbggcs-ko2, were assessed during the erythrocytic cycle
Fig. 5. Levels of protein carbonylation in intraerythrocytic stages fromWT and mutant parasites. Levels of protein carbonylation were assessed in WT, pbggcs-ko, and pbgr-ko
parasites using the FTC ﬂuorescent assay. Panel A: protein carbonyl content in intraerythrocytic asynchronous blood stages. Panel B: protein carbonyl content in cultured
schizonts. No signiﬁcant differences in the levels of protein carbonylations were observed between WT and mutant intraerythrocytic asynchronous parasites and cultured
schizonts. Bars represent the SEM of 4 independent experiments from intraerythrocytic stages and SD of 2 independent experiments from cultured schizonts.
Table 3
Protein carbonylation content in wild type versus mutant parasites.
WT pbggcs-ko1 pbggcs-ko2 pbgr-ko1 pbgr-ko2
Mixed asexual stages (nmol/mg7SEM) 22167312 25067272 25027320 32347630 29457931
Schizonts stages (nmol/mg7SD) 5496755 520771452 552673401 700671257 442871568
Fold 2.48 2.08 2.21 2.17 1.50
Fig. 6. P. berghei ggcs-ko parasites show upregulated levels of sod, grx and rnr
mRNA expression. The relative gene expression was determined by RT-qPCR and
expressed as fold change for the pbggcs-ko2 and pbgr-ko2 as compared to WT. The
data was normalized against the expression of 18S rRNA. The sod (superoxide
dismutase), grx (glutaredoxin) and rnr (ribonucleotide reductase) genes showed
increased gene expression in the pbggcs-ko2 mutant parasites (***po0.001) ana-
lyzed by Two-way ANOVA with Bonferroni multiple comparison test. Bars re-
present the SEM from 3 independent experiments. Red dotted line represents the
expression level in WT parasites. (For interpretation of the references to color in
this ﬁgure legend, the reader is referred to the web version of this article.)
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stained cultured parasites revealed a signiﬁcant size reduction and
increased vacuolated cytoplasm in the mutants (Fig. 1G). A sig-
niﬁcant reduction in size was observed in both pbggcs-ko1 and the
pbggcs-ko2 trophozoites at 16 h of culture (po0.05 and po0.01,
respectively) and in schizonts at 24 and 28 h of culture (po0.001
and po0.001) (Fig. 1E and F). To further analyze the morphology,
the number of parasites with vacuolated cytoplasm was de-
termined. A remarkable number of the mutant parasites displayed
vacuoles in their cytoplasm (60%, pbggcs-ko1 and 45%, pbggcs-ko2),(Figs. 1G and S1–S3). These results suggest that low GSH levels
result in morphological changes and a signiﬁcant delay of the in-
traerythrocytic development in P. berghei.
3.2. P. berghei ggcs deﬁcient parasites display augmented in-
tracellular oxidation of DCFH and an impaired response to oxidative
stress
In order to determine whether depleted GSH is associated with
an increase in oxidative stress, the green ﬂuorescent intensity of
DCF, the oxidation product of the nonﬂuorescent probe DCFH, was
measured in WT and mutant parasites. The pbggcs-ko2 (GSH le-
vels: 0.2 nmol/109 parasites [14]), show higher levels of DCF
ﬂuorescence under basal conditions when compared to WT
parasites as depicted in Fig. 2A (130–140 min; po0.05, po0.01).
Similarly, DCF ﬂuorescence under basal conditions is higher in
pbggcs-ko2 (1.9-fold) as compared to pbgr-ko1 (GSH levels:
5.0 nmol/109 parasites [15]) (Fig. 2A). There were no basal differ-
ences in intracellular oxidation, as determined by DCF ﬂuores-
cence, between the pbgr-ko1 and the WT parasites.
To test the response to exogenous oxidative stress the parasites
were exposed to H2O2. Treatment with 2 mM H2O2 had no effect
on DCF ﬂuorescent intensity in the WT or pbgr-ko1 parasites
(Fig. 2B). In contrast, incubation with H2O2 signiﬁcantly increased
(2.3 fold) the oxidation of DCFH in pbggcs-ko2 parasites as com-
pared to WT as depicted in Fig. 2B (100–140 min; po0.01,
po0.001). Similarly, incubation of pbggcs-ko2 with H2O2 sig-
niﬁcantly increased (2.5 fold) the oxidation of DCFH as compared
to pbgr-ko1 (110–140 min; po0.05, po0.01, po0.001) (Fig. 2B).
These results suggest that the pbggcs-ko2 parasites with low GSH
levels exhibit higher basal oxidative stress and an impaired re-
sponse to exogenous oxidative stress than the WT or the pbgr-ko1
parasites.
Fig. 7. Proposed effects of GSH deﬁciency in P. berghei during asexual blood stages. Representation of the P. berghei intracellular blood stage with the biochemical processes
involved in the antioxidant defense. The red circle represents the red blood cell and the blue circle represents the parasite and the biochemical antioxidant pathways. The
pbggcs-ko mutant parasites with signiﬁcantly low GSH levels exhibit growth delay during intraerythrocytic development probably due to an impaired response to oxidative
stress and nDNA damage. As a result of increased oxidative stress, the pbggcs-ko mutant parasites increase expression of sod for cytosolic dismutation of the superoxide, and
grx and rnr to support dNTP synthesis. These events may be necessary to sustain development of P. berghei parasite in the absence of GSH. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
V. Padín-Irizarry et al. / Free Radical Biology and Medicine 95 (2016) 43–54503.3. pbggcs-ko parasites show increased levels of nuclear DNA
damage
To investigate whether reduced GSH levels cause damage to the
parasite’s DNA, a QPCR assay was used to quantify the levels of
nuclear (nDNA) and mitochondrial DNA (mtDNA) damage [22]. To
measure nDNA damage in the WT, pbggcs-ko and pbgr-ko para-
sites, a 6.1 kb nDNA fragment of the P. berghei seryl t-RNA syn-
thetase gene was ampliﬁed. The pbggcs-ko2 parasites show a sig-
niﬁcant (po0.001) 38.5% reduction in the ampliﬁcation of the
6.1 kb nDNA fragment (Fig. 3A), indicating an increase in levels of
nDNA damage (Fig. 3B), compared to WT, whereas the ampliﬁca-
tion levels of the 6.1 kb nDNA fragment from the pbggcs-ko1, pbgr-
ko1 and pbgr-ko2 were similar to those of the WT parasites
(Fig. 3A). The frequency of nDNA lesions was 10.6-fold higher for
the pbggcs-ko2 parasites compared to WT parasites (po0.01)
(Fig. 3B). However, no statistically signiﬁcant differences in the
number of nDNA lesions between the WT, the pbggcs-ko1, or pbgr-
ko mutant parasites were detected.
The levels of mtDNA lesions in the WT and the mutant para-
sites were also determined by amplifying a 5.7 kb mtDNA frag-
ment which represents 95% of the mitochondrial genome [27]. The
analysis revealed no signiﬁcant differences in the relative ampli-
ﬁcation of the mtDNA fragment between the pbggcs-ko, the pbgr-
ko or the WT parasites, demonstrating no increase in mtDNA da-
mage (Fig. 4A). Because high oxidative stress levels can affect the
replication rates of the mtDNA, the steady-state levels of mtDNA
molecules were assessed in WT, pbggcs-ko, and pbgr-ko. Steady-
state levels of mtDNA molecules were similar in the mutant and
the WT parasites (Fig. 4B). Collectively, these results suggest thatparasites with reduced GSH levels show an increase in nDNA da-
mage but no increase in damage to the mitochondrial genome.
3.4. Reduced GSH levels have no effect on protein carbonyl content in
parasite intraerythrocytic stages
Protein carbonylation is one of the most common protein
modiﬁcations caused by oxidative stress [28]. The extent of protein
carbonylation was examined in total protein extracts from WT,
pbggcs-ko and pbgr-ko mixed asynchronous blood stages and from
synchronized schizonts cultures using the FTC ﬂuorometric assay.
The amount of carbonylated proteins from the intraerythrocytic
blood stages of pbggcs-ko and pbgr-ko mutants was similar to
those detected in the WT parasites (Fig. 5A). Similar results were
obtained when protein carbonyls were measured using the dini-
trophenylhydrazine (DNPH) method (Fig. S4). Cultured schizonts
from mutant and WT parasites exhibited a 1.5–2.5 fold increase in
carbonyl content as compared to the intraerythrocytic parasites
(Fig. 5B; Table 3). However, no signiﬁcant differences (One-way
ANOVA and unpaired t-test) were observed between the mixed
blood stages and cultured schizonts.
3.5. GSH depletion induces upregulation of genes involved in de-
toxiﬁcation and DNA synthesis
To establish whether or not reduced GSH levels affects the
expression of genes involved in oxidative detoxiﬁcation and DNA
synthesis, the mRNA levels of the superoxide dismutase (sod),
glutaredoxin (grx) and ribonucleotide reductase (rnr) genes were
determined in the pbggcs-ko2, the pbgr-ko1 and the WT parasites.
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pbggcs-ko2 parasites as compared to the WT, while no differences
in gene expression were observed between the pbgr-ko1 and the
WT parasites (Fig. 6). The P. berghei SOD, an enzyme responsible
for the dismutation of the superoxide anion (O2d), was upregu-
lated (9.6-fold induction) in the pbggcs-ko2 parasites (po0.01).
The glutaredoxin (Grx) enzyme serves as a hydrogen-donor for
RNR in the ﬁrst step of DNA synthesis. Both grx and rnr genes
showed a signiﬁcant increase in expression in the pbggcs-ko2
parasites, with 13.7 and 10-fold upregulation, respectively
(po0.001). These results suggest that P. berghei parasites ex-
hibiting GSH depletion display increased expression of genes in-
volved in ROS detoxiﬁcation and DNA synthesis.4. Discussion
Previous work from our laboratory showed that the Plasmo-
dium GSH metabolism is dispensable for parasite development
during the intraerythrocytic cycle [2,3]. However, low GSH levels
delayed progression of the infection in mice, presumably by ex-
tending the parasite’s cellular cycle in order to compensate for the
absence of the GSH antioxidant [2]. In this study we show that
pbggcs-ko parasites with low GSH levels exhibit a delay in the ring
to schizont progression, an impaired response to increased oxi-
dative stress, and an increase in nDNA damage. In addition, we
report an increase in mRNA expression of genes involved in oxi-
dative stress detoxiﬁcation and DNA synthesis. These results sug-
gest that optimal GSH levels are needed in order to protect the P.
berghei nuclear genome from oxidative stress and for proper de-
velopment. Furthermore, due to the impaired response to external
oxidative stress, parasites will face a major hurdle to grow under
conditions where environmental oxidative stress is high, such as
the infected erythrocytes [3] and particularly the internal com-
partments of the mosquito host [14,15].
In previous work, we reported that pbggcs-ko mutant parasites
exhibit a delayed development in mice [14]. In this work we ob-
served a 2-h delay in the transition from rings to trophozoites, and
a 4–6-h delay in the transition from trophozoites to schizonts
when comparing the pbggcs-ko1 and pbgccs-ko2 mutants to the
WT parasites. Our non-linear Weibull model of the schizont
growth reveals a 2-h delay in the growth between the mutants
and the WT parasites. Results from the present study also show a
highly signiﬁcant correlation between GSH levels and the delayed
transition from ring to schizonts (r2¼1.0, p¼0.013), supporting the
notion that GSH plays an important role on Plasmodium growth
development. The observed delay and smaller size of the pbggcs-ko
parasites suggest a slow-down in the cell cycle presumably to
repair the oxidative damage observed in the nuclear genome. This
is consistent with previous observations where a Candida albicans
and a Saccharomyces cerevisiae strain harboring a deletion in the
ggcs homolog, showed decreased growth rates and prolonged cell
cycle [29,30]. Additional evidence supporting the hypothesis that
low GSH levels affect cell growth is provided by studies of human
3T3 ﬁbroblasts treated with diethyl maleate, an agent that de-
creases nuclear GSH levels, resulted in slower cell cycle [31]. Si-
milarly, we speculate that a longer cell cycle during P. berghei in-
traerythrocytic stages could provide the parasite with enough time
to repair the oxidative damage to the nDNA occurring as a con-
sequence of low GSH levels.
It should be pointed out that in contrast to P. berghei, deletion
of the γGCS or glutathione synthetase genes was lethal for P. fal-
ciparum, suggesting that GSH levels are critical for P. falciparum
development [32]. It is possible that P. falciparum is incapable of
uptaking sufﬁcient amounts of GSH from the mature RBC to allow
parasite survival during the erythrocytic cycle [32,33].Furthermore, P. falciparum infected RBC display increased GSH
efﬂux [34], which may result in a decrease in GSH available for
parasite uptake. P. berghei prefers to invade young erythrocytes
(reticulocytes), which are metabolically different from mature
RBC, supporting the hypothesis that host environment have an
impact on parasite growth and survival [34,35]. Differences be-
tween both species should be taken into consideration and the
GSH uptake in P. berghei be further evaluated, since the pbggcs-ko
parasites have reduced but detectable GSH levels.
Plasmodium parasites depend on the digestion of hemoglobin
as a major amino acid source. Heme/FP IX (Fe2þ/Fe3þ), generated
as a by-product of Hb digestion, is toxic for the parasite and is
detoxiﬁed via a biomineralization process into hemozoin, a che-
mically inert crystal that confers the distinctive pigment of Plas-
modium parasites [36–39]. However, some heme/FP IX
(Fe2þ/Fe3þ) escapes the biomineralization process and reaches
the cytosol [40,41] resulting in the generation of the superoxide
(O2d) [4,42]. The superoxide (O2d) can be dismutated by the
cytosolic superoxide dismutase (SOD) to H2O2 and O2 and can
react with H2O2 to form the highly reactive hydroxyl radical (dOH)
[3]. In addition, free iron released from heme/FP IX (Fe2þ/Fe3þ)
acts as a pro-oxidant mediating the generation of hydroxyl (dOH)
via the Fenton reaction [3]. To maintain low levels of oxidants the
parasites uses the GSH antioxidant system. The pbggcs-ko para-
sites, with low GSH levels are unable to detoxify the non-crystal-
lized heme/FP IX and thus, will potentially have higher levels of
free iron (Fe2þ/Fe3þ) and consequently higher levels of oxidative
stress. It is plausible that in a low GSH environment like the one
present in the pbggcs-ko, the parasites are unable to prevent the
harmful effects of the FP IX; resulting in enhanced oxidative stress,
leading to parasite growth delay and changes in the morphology
during development. The H2O2 treatment signiﬁcantly increased
the oxidation of DCFH in the pbggcs-ko2 parasites when compared
to the WT and pbgr-ko1 parasites, further supporting that low GSH
levels are associated with increased oxidative stress. It is possible
that the heme/FP IX (Fe2þ/Fe3þ) produced from Hb digestion may
have promoted H2O2-induced DCFH oxidation. This idea is con-
sistent with evidence showing that the H2O2-induced intracellular
DCFH oxidation in bovine aortic endothelial cells is facilitated by
uptake of iron mediated by the transferrin receptor [43]. Hence,
we conclude that the mutant parasites have an impaired system to
handle oxidative stress.
Our observations are consistent with studies where conditions
leading to increased oxidative stress in P. falciparum cultures re-
sulted in parasite growth delay [19,44,45]. Treatments that pro-
mote oxidative stress such as clotrimazole [19], pro-oxidant con-
centrations of curcumin [44] or bilirubin [45] result in increased
accumulation of ROS and inhibition of parasite growth [19]. In
addition, treatment with the antimalarial drug artesunate leads to
increased oxidative stress and reduced GSH levels, causing parasite
death [46]. The association between inhibition of parasite growth
and increased oxidative stress was further supported by the ad-
dition of antioxidants that restored parasite growth [46]. Inter-
estingly, our results show that the pbgr-ko1 parasites with inter-
mediate levels of GSH did not present growth delay (5.0 nmol/109
parasites) [15] nor increased oxidation of DCFH. These data sug-
gest that the increase in oxidative stress and the parasite growth
delay are a consequence of reduced GSH levels as is the case for
the pbggcs-ko parasites. We hypothesize that there is a threshold
in the GSH levels required for normal P. berghei intraerythrocytic
development.
Interestingly, an increase of nDNA damage was detected in
pbggcs-ko2 parasites with low GSH levels (0.2 nmol/109 parasites
[14]). This observation supports the notion that the increased
oxidative stress associated with GSH depletion leads to the in-
duction of oxidative damage in the P. berghei nuclear genome. Our
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demonstrating that nDNA damage is associated with GSH deple-
tion and increased oxidative stress after artesunate treatment [46].
It should be noted that neither the pbgccs-ko1 (GSH levels of
1.0 nmol/109 parasites [14]) nor the pbgr-komutants (GSH levels of
5.0 nmol/109 parasites [15]) show a statistically signiﬁcant in-
crease in nDNA damage compared to WT (GSH levels of
7.4 nmol/109 parasites [14]), demonstrating that only a drastic
reduction in GSH levels (i.e. the 97% reduction in GSH levels de-
tected in the pbggcs-ko2 when compared to WT) are associated
with increased oxidation of DCFH and nDNA damage. Surprisingly,
increased mtDNA damage or changes in the abundance of mtDNA
molecules in the pbggcs-ko parasites were not detected, suggesting
that under physiological conditions, damage to the nDNA and not
the mtDNA may lead to P. berghei growth delay. In contrast, P.
falciparum parasites treated with high pro-oxidant concentrations
of curcumin resulted in increased damage to both the nuclear and
mitochondrial genomes [44]. Mitochondria are the main ROS
producers in the cell, mainly as a byproduct of oxidative phos-
phorylation [47]. Although Plasmodium parasites are fully capable
of mitochondrial oxidative phosphorylation during the in-
traerythrocytic stages [48], they rely on anaerobic glycolysis as the
main source of energy [49,50] using the electron transport chain
mainly for de novo pyrimidine biosynthesis [51,52]. Our results
showed that the absence of mtDNA damage under depleted GSH
levels is in agreement with Plasmodium mitochondria not being
the main source of ROS during the intraerythrocytic development.
These results suggest that GSH plays a role in protecting the nu-
clear genome from oxidative stress.
Surprisingly, no signiﬁcant changes in the amounts of protein
carbonyl content in the pbggcs-ko or pbgr-ko parasites were de-
tected in our analysis, suggesting that reduced GSH levels did not
increase oxidative damage to proteins. Radfar et al. [53] reported
that in P. falciparum cultures, chloroquine treatment led to an in-
crease in protein carbonylation mainly in the mature schizont.
Chloroquine is hypothesized to prevent hemozoin formation al-
lowing the release of ferroprotoporphyrin IX (FP IX), which in
turns induces oxidative stress (lethal to the parasite). Although a
similar environment of increased oxidative stress is present in the
pbggcs-ko mutants due to the signiﬁcantly reduced GSH levels, our
results show that the GSH deﬁciency did not further increase the
levels of oxidized proteins neither in the intraerythrocytic stages
nor in the synchronized schizont cultures.
The mRNA expression of sod, an enzyme responsible for the
dismutation of O2 into H2O2 [54] was signiﬁcantly upregulated in
the pbggcs-ko2 deﬁcient parasites but not in pbgr-ko2 parasites.
The upregulation of cytosolic sod mRNA could be a protective re-
sponse to the increased oxidative stress levels observed in the GSH
depleted pbggcs-ko2 mutants. The SOD enzyme represents an
important antioxidant defense of Plasmodium parasites [55]. Two
Plasmodium SODs have been identiﬁed, PfSOD1 and PfSOD2 [56],
but the iron-dependent cytosolic PfSOD1 has been shown to be
highly expressed in the intraerythrocytic stages [57]. Our results
suggest that the extreme reduction of GSH levels in the pbggcs-ko2
mutants induces an increase in the expression of the antioxidant
genes presumably as a response to oxidative stress.
Optimal levels of dNTPs are required for DNA replication and
DNA repair, a reaction catalyzed by RNR, the rate-limiting enzyme
during DNA synthesis. The Grx enzyme can reduce RNR and exert
redox regulation, cell growth and proliferation activities. Analysis
of the P. berghei mutant parasites revealed that the grx and rnr
genes displayed a signiﬁcant increase in mRNA expression in the
pbggcs-ko2 parasites, while no differences were detected in the
pbgr-ko2 parasites. These results suggest that depletion of GSH is
associated with a signiﬁcant induction in the grx and rnr expres-
sion, probably in response to the oxidative damage observed innDNA of the mutant parasites. These results are in agreement with
ﬁndings showing induction of the RNR enzyme by DNA damage
[58]. It is plausible that the pbggcs-ko parasites increased synthesis
of dNTPs for DNA replication to compensate for deﬁciencies in
proliferation or to repair the oxidative damage observed in the
nDNA. However, these changes in gene expression are not de-
tected in the pbgr-ko2 parasites, which show normal growth
during the intraerythrocytic cycle [15] and no lesions in nDNA,
suggesting that intermediate GSH levels are sufﬁcient for normal
parasite growth.
The reduced GSH levels present in the pbggcs-ko parasites have
implications for antimalarial treatments [59]. We recently re-
ported that the pbggcs-ko parasites were more sensitive to clear-
ance after sublethal doses of artemisinin (ART) treatment in a
recrudescence assay [59]. These results suggest that GSH con-
tributes to the ART response, making the parasites more tolerant
to the drug. In addition, RRx-001, a new agent that inhibits the
pentose phosphate pathway (PPP) of the parasite, was effective
against P. berghei cerebral malaria and enhanced the activity of
artemether when used in combination [60]. The PPP provides the
only source of NADPH used by the parasite’s GSH and the Trx
systems during protection against the harmful effects of oxidative
stress. This drug also binds to Hb and GSH, increasing the ROS
levels and oxidative damage caused by artemether [61]. These
reports together with our results encourage research to explore
drugs that inhibit the GSH biosynthesis of the parasite as a po-
tential combination drug for ART treatment.
This study provides evidence supporting that GSH deﬁcient
parasites exhibit a growth delay and damage to the nuclear gen-
ome during development of the intraerythrocytic stages. The re-
duced GSH levels did not increase damage to the parasite’s mi-
tochondrial genome nor protein carbonylation of the parasites.
This report highlights a potential key role of GSH to support
parasite development and to protect the nuclear genome from
oxidative damage (Fig. 7). A threshold level of GSH appears to be
necessary to observe the effects of oxidative stress in the parasite.
Further work will be needed to clearly establish the existence of a
GSH threshold level. Understanding the mechanisms that result in
the inhibition of parasite development represents a promising
approach for the development of new antimalarial drugs [62].Conﬂict of interests
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